Page 23 - கோர் வங்கி அமைப்பு மென்பொருள் சந்தை ஔட்‌லுக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கோர் வங்கி அமைப்பு மென்பொருள் சந்தை ஔட்‌லுக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கோர் வங்கி அமைப்பு மென்பொருள் சந்தை ஔட்‌லுக் Today - Breaking & Trending Today

Lyxor Core UK Government Bond (DR) UCITS ETF - Dist: Net Asset Value(s)


Lyxor Core UK Government Bond (DR) UCITS ETF - Dist: Net Asset Value(s)
DJ Lyxor Core UK Government Bond (DR) UCITS ETF - Dist: Net Asset Value(s)
Lyxor Core UK Government Bond (DR) UCITS ETF - Dist (GILS LN)
Lyxor Core UK Government Bond (DR) UCITS ETF - Dist: Net Asset Value(s)
12-Apr-2021 / 10:15 CET/CEST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
=
Net Asset Value(s)
FUND: Lyxor Core UK Government Bond (DR) UCITS ETF - Dist
DEALING DATE: 09-Apr-2021
NAV PER SHARE: GBP: 140.8041 ....

Kostenloser Wertpapierhandel , News Service , Core United Kingdom Government Bond , Net Asset Value , Lyxor Core United Kingdom Government Bond , Regulatory Announcement , Asset Value , Dow Jones Newswires , செய்தி சேவை , நிகர சொத்து மதிப்பு , ஒழுங்குமுறை அறிவிப்பு , சொத்து மதிப்பு ,

Core One Labs Inc.: Core One Labs Vocan Expands Product Commercialization Team


Core One Labs Inc.: Core One Labs Vocan Expands Product Commercialization Team
Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the
Company or
Core One ) is pleased to announce its wholly-owned subsidiary Vocan Biotechnologies Inc. (
Vocan ) has expanded its product commercialization team, adding Dr. Elizabeth Matthews as Head of Scientific and Regulatory Affairs.
Dr. Matthews will oversee research and development, as well as the commercialization of Vocan s new product offerings, including the navigation of regulatory processes involved during transition from laboratory to market.
Dr. Matthews brings extensive experience as both a scientist and a regulatory affairs expert, and her knowledge of, and aptitude in, navigating regulatory processes and eligibility requirements for scientific products will effectively mitigate timelines in getting Vocan s proprietary alternative medicinal products to market. Dr. Matthews is a mic ....

United Kingdom , British Columbia , Joel Shacker , University Of St , University Of Victoria , Regulatory Affairs , Core One Labs Inc , Vocan Biotechnologies Inc , Health Canada , Canadian Securities Exchange , Company Or Core , Regulatory Affairs Management , Core One Labs , Vocan Biotechnologies , Elizabeth Matthews , Quality Assurance , Pfizer Canada , Green Sky Labs , Disclaimer Statement , Controlled Drugs , Substances Act , Core One , ஒன்றுபட்டது கிஂக்டம் , பிரிட்டிஷ் கொலம்பியா , ஜோயல் குலுக்கல் , பல்கலைக்கழகம் ஆஃப் ஸ்டம்ப் ,